Ruth Birbe

3.6k total citations
50 papers, 2.7k citations indexed

About

Ruth Birbe is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ruth Birbe has authored 50 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Ruth Birbe's work include Cancer, Hypoxia, and Metabolism (13 papers), Metabolism, Diabetes, and Cancer (9 papers) and Cancer-related Molecular Pathways (8 papers). Ruth Birbe is often cited by papers focused on Cancer, Hypoxia, and Metabolism (13 papers), Metabolism, Diabetes, and Cancer (9 papers) and Cancer-related Molecular Pathways (8 papers). Ruth Birbe collaborates with scholars based in United States, United Kingdom and Italy. Ruth Birbe's co-authors include Ubaldo Martinez‐Outschoorn, Diana Whitaker‐Menezes, Michael P. Lisanti, Federica Sotgia, Anthony Howell, Richard G. Pestell, Agnieszka K. Witkiewicz, Neal Flomenberg, Adam Ertel and Stephanos Pavlides and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Ruth Birbe

49 papers receiving 2.7k citations

Peers

Ruth Birbe
Enping Xu China
Ruth Birbe
Citations per year, relative to Ruth Birbe Ruth Birbe (= 1×) peers Enping Xu

Countries citing papers authored by Ruth Birbe

Since Specialization
Citations

This map shows the geographic impact of Ruth Birbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Birbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Birbe more than expected).

Fields of papers citing papers by Ruth Birbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Birbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Birbe. The network helps show where Ruth Birbe may publish in the future.

Co-authorship network of co-authors of Ruth Birbe

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Birbe. A scholar is included among the top collaborators of Ruth Birbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Birbe. Ruth Birbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roche, Megan, Ying‐Hui Ko, Marina Domingo‐Vidal, et al.. (2023). TP53 Induced Glycolysis and Apoptosis Regulator and Monocarboxylate Transporter 4 drive metabolic reprogramming with c‐MYC and NFkB activation in breast cancer. International Journal of Cancer. 153(9). 1671–1683. 18 indexed citations
2.
Birbe, Ruth, et al.. (2022). Epidermoid cyst: An unusual presentation of a testicular mass. Current Urology. 16(4). 267–268.
3.
Thangavel, Chellappagounder, Ettickan Boopathi, Yi Liu, et al.. (2018). Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non–Small Cell Lung Cancer. Clinical Cancer Research. 24(6). 1402–1414. 39 indexed citations
4.
Johnson, Jennifer M., Paolo Cotzia, Lekha Mikkilineni, et al.. (2017). MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer. Frontiers in Cell and Developmental Biology. 5. 27–27. 57 indexed citations
5.
Monti, Daniel, Federica Sotgia, Diana Whitaker‐Menezes, et al.. (2017). Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer. Seminars in Oncology. 44(3). 226–232. 49 indexed citations
6.
Perepelyuk, Maryna, Ruth Birbe, Chellappagounder Thangavel, et al.. (2017). siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer. Molecular Therapy — Nucleic Acids. 6. 259–268. 14 indexed citations
7.
Tripathi, Sushil, Edouard J. Trabulsi, Leonard G. Gomella, et al.. (2015). VPAC1 Targeted 64Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man. Urology. 88. 111–118. 24 indexed citations
8.
Dutta, Anindita, Jing Li, Huimin Lu, et al.. (2014). Integrin αvβ6 Promotes an Osteolytic Program in Cancer Cells by Upregulating MMP2. Cancer Research. 74(5). 1598–1608. 58 indexed citations
9.
Thangavel, Chellappagounder, Ettickan Boopathi, Yi Liu, et al.. (2014). The Retinoblastoma Tumor Suppressor Modulates DNA Repair and Radioresponsiveness. Clinical Cancer Research. 20(21). 5468–5482. 20 indexed citations
10.
Schrecengost, Randy S., Jeffry L. Dean, Jonathan F. Goodwin, et al.. (2013). USP22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer Progression. Cancer Research. 74(1). 272–286. 99 indexed citations
11.
Draganova‐Tacheva, Rossitza, Marluce Bibbo, Ruth Birbe, Constantine Daskalakis, & Charalambos Solomides. (2013). The Potential Value of Phosphohistone-H3 Mitotic Index Determined by Digital Image Analysis in the Assessment of Pancreatic Endocrine Tumors in Fine-Needle Aspiration Cytology Specimens. Acta Cytologica. 57(3). 291–295. 15 indexed citations
12.
Martinez‐Outschoorn, Ubaldo, Joseph Curry, Ying‐Hui Ko, et al.. (2013). Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment. Cell Cycle. 12(16). 2580–2597. 69 indexed citations
13.
Solomides, Charalambos, Ruth Birbe, Nicos Nicolaou, Demetrius H. Bagley, & Marluce Bibbo. (2012). Does Mitosis-Specific Marker Phosphohistone H3 Help the Grading of Upper Tract Urothelial Carcinomas in Cell Blocks?. Acta Cytologica. 56(3). 285–288. 8 indexed citations
14.
Ertel, Adam, Aristotelis Tsirigos, Diana Whitaker‐Menezes, et al.. (2012). Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolism. Cell Cycle. 11(2). 253–263. 54 indexed citations
15.
Augello, Michael A., Craig J. Burd, Ruth Birbe, et al.. (2012). Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes. Journal of Clinical Investigation. 123(1). 493–508. 35 indexed citations
16.
Chiavarina, Barbara, Diana Whitaker‐Menezes, Ubaldo Martinez‐Outschoorn, et al.. (2011). Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth. Cancer Biology & Therapy. 12(12). 1101–1113. 98 indexed citations
17.
Whitaker‐Menezes, Diana, Ubaldo Martinez‐Outschoorn, Neal Flomenberg, et al.. (2011). Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ. Cell Cycle. 10(23). 4047–4064. 237 indexed citations
18.
Snook, Adam E., Peng Li, Gene S. Tan, et al.. (2008). Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity. JNCI Journal of the National Cancer Institute. 100(13). 950–961. 46 indexed citations
19.
Debruyne, Philip R., Matthew E. Witek, Li Gong, et al.. (2006). Bile Acids Induce Ectopic Expression of Intestinal Guanylyl Cyclase C Through Nuclear Factor-κB and Cdx2 in Human Esophageal Cells. Gastroenterology. 130(4). 1191–1206. 84 indexed citations
20.
Birbe, Ruth, et al.. (2004). Gliosarcoma arising from an anaplastic ependymoma: a case report of a rare entity. Human Pathology. 35(4). 512–516. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026